Objective: To assess temporal trends in 1-year healthcare costs and outcome of intensive care for traumatic brain injury in Finland. Design: Retrospective observational cohort study. Setting: Multicenter study including four tertiary ICUs. Patients: Three thousand fifty-one adult patients (≥ 18 yr) with significant traumatic brain injury treated in a tertiary ICU during 2003–2013. Intervention: None. Measurements and Main Results: Total 1-year healthcare costs included the index hospitalization costs, rehabilitation unit costs, and social security reimbursements. All costs are reported as 2013 U.S. dollars ($). Outcomes were 1-year mortality and permanent disability. Multivariate regression models, adjusting for case-mix, were used to assess temporal trends in costs and outcome in predefined Glasgow Coma Scale (3–8, 9–12, and 13–15) and age (18–40, 41–64, and ≥ 65 yr) subgroups. Overall 1-year survival was 76% (n = 2,304), and of 1-year survivors, 37% (n = 850) were permanently disabled. Mean unadjusted 1-year healthcare cost was $39,809 (95% CI, $38,144–$41,473) per patient. Adjusted healthcare costs decreased only in the Glasgow Coma Scale 13–15 and 65 years and older subgroups, due to lower rehabilitation costs. Adjusted 1-year mortality did not change in any subgroup (p
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2CcWA4Q
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
High-altitude cerebral edema To: Neuroimaging features of fatal high-altitude cerebral edema p. 401 Gorky Medhi, Tsella Lachungpa, Jitender ...
-
Note: Page numbers of article titles are in boldface type. from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2aggaBB
-
Abstract Birch pollen allergy is a common cause of spring pollinosis in China. However, there is little research on birch pollen allergen ...
-
A Phase 2 Study of Actinium-225 (225Ac)-Lintuzumab in Older Patients with Untreated Acute Myeloid Leukemia (AML) - Interim Analysis of 1.5 µ...
-
Zusammenfassung Die spinale Muskelatrophie (SMA) ist eine progressive, autosomal-rezessive neurodegenerative Erkrankung mit einer Inzidenz...
-
Abstract Hydrogen has been considered one of the best energy carriers to satisfy the increasing demand for clean and renewable energy supp...
-
Abstract Objective To date, there are no definitive biomarkers for diagnose Parkinson's disease (PD). The detection of α-synuclein (...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου